Kaniz Afroz Tanni

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Palliative Care

Quality Improvement

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Saranrat Sadoyu, Kaniz Afroz Tanni, Nontaporn Punrum, Sobhon Paengtrai, Warittakorn Kategaew, Nattiwat Promchit, Nai Ming Lai, Ammarin Thakkinstian, Surachat Ngorsuraches, Mukdarut Bangpan, Sajesh Veettil, Nathorn Chaiyakunapruk
Methodological approaches for assessing certainty of the evidence in umbrella reviews: A scoping review. PloS one 17 (6) (2022)
Kaniz Afroz Tanni, Cong Bang Truong, Sura Almahasis, Jingjing Qian
Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)
Jingjing Qian, Cong Bang Truong, Kaniz Afroz Tanni
Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database". BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (3) (2021)